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136 staphylococci was 94.8% (129/136) accordance with the phe-
notype results and 100% accordance with the sequencing results.
Staphylococci were identiﬁed to common macrolides resistance
genes and the positive probability was 75.7% (103/136). The
results of 110 Escherichia coli and 94 Klebsiella pneumoniae was
97.1% (198/204) accordance with the phenotype results and 100%
accordance with sequencing results. Common beta-lactamases
resistance genes positive probability were 42.7% (47/110) in
Escherichia coli and 36.2% (34/94) in Klebsiella pneumoniae.
Conclusion Multiplex real-time SYBR Green I PCR combining
melt temperature assay can screen rapidly and identify accu-
rately common macrolides resistance genes in staphylococci and
beta-lactamases resistance genes in Escherichia coli or Klebsiella
pneumoniae. The multiple detection platform can be applied to
detect common resistance genes in clinical specimen and the
method has important value in instructing clinician to prescribe
accurate antibiotics and monitoring for resistance epidemiology.
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monocytes, correlate with disease progression in
chronic HIV-infected patients
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Objectives: CD14+CD16+ monocytes are an important cellular
target for HIV-1 entry and expand in the peripheral blood
of HIV-infected individuals. Since CD14+CD16+ monocytes are
a heterogeneous population and consist of CD14highCD16+ and
CD14lowCD16+ subsets, we evaluated the effects of HIV infection
on distinct subsets of CD16+ monocytes.
Methods: Untreated HIV-infected patients were recruited to in-
vestigate the relationship between the proportions of monocyte
subsets with plasma viral loads and CD4+ T cell counts. Pa-
tients receiving HAART were followed in a cross-sectional and
longitudinal study, respectively.
Results: Compared with CD14lowCD16+, CD14highCD16+ monocytes
showed higher levels of CD64 and HLA-DR antigens, which implies
that these two distinct subsets have different immunoregula-
tory phenotypes. In HAART-naïve patients, elevated proportions
of CD14highCD16+ monocytes were correlated with increased vi-
ral loads, as well as decreased CD4+ T-cell counts, whereas
CD14lowCD16+ monocytes did not show such correlation with dis-
ease progression. Of importance, HAART recovered the propor-
tion of CD14highCD16+ monocytes, whereas CD14lowCD16+ mono-
cytes did not decrease during 1 year of antiviral therapy.
Conclusions: Taken together, our observations elucidate distinct
immune responses of monocyte subsets during HIV infection and
antiviral therapy, and provide new insight into the roles of innate
immunity in HIV-related pathogenesis.
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PL-008 Receptor binding proﬁle of H5N1 inﬂuenza virus
correlates with glycosylation of HA and length of
NA stalk
Chao-Tan Guo*, En-Kang Wo, Hai-Bo Wu. Zhejiang Academy of
Medical Sciences
Background: Transmission of H5N1 inﬂuenza viruses from poultry
to humans and from humans to humans is currently inefﬁcient.
However, when such transmission occurs, the case-fatality ratio
is high.
Methods: 55 H5N1 isolates in recent years could be divided into
three groups based on receptor binding speciﬁcity for the avian-
type, the human-type and both types of receptors. Analyses of
HA and NA sequences of these viruses revealed motifs associated
with the receptor binding proﬁle. We determined that glycosyla-
tion of HA and length of NA stalk inﬂuenced the receptor binding
speciﬁcities of viruses using a reverse genetic system. The viruses
having two glycosylation at positions 158 and 169 in HA lacked
the binding activities to human-type receptor.
Results: Data of their binding speciﬁcity and their replication
in different type cells indicates the length of NA stalk was as-
sociated with the receptor binding proﬁle, further act on the
replication of viruses. Viruses which match with HA having two
glycosylation sites and short-stalked NA bound preferentially to
avian-type receptor and adapted to poultry. Viruses which match
with HA lacking glycosylation and short-stalked NA bound both
avian- and human-type receptors.
Conclusion: We found two critical factors favoring H5N1 infec-
tion from humans to humans: no glycosylation site at 158 of
HA, and NA with a full-length stalk. Such viruses might be more
likely to be transmitted from humans to humans. These features
are important molecular markers of H5N1 viruses with increased
pandemic potential.
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PL-009 Interferon and nucleoside/tide analog reduce risk
of hepato-cellular carcinoma among hepatitis B
patients: a meta-analysis
Kelvin K.F. Tsoi *, Vincent W.S. Wong, Henry L.Y. Chan, Joseph
J.Y. Sung. Institute of Digestive Disease, Chinese University of
Hong Kong
Objectives: The effects of treatment in preventing hepatocellu-
lar carcinoma (HCC) is not clear. We studied effects of interferon
(IFN) or nucleoside/tide analog (NA) on the risk of developing
HCC in Chronic hepatitis B infection (CHB) patients.
Methods: Full publications and abstracts from MEDLINE, EMBASE,
the Cochrane Central Register of Controlled Trials, the Database
of Abstracts of Reviews of Effects, and the International Pharma-
ceutical Abstracts were retrieved. Abstracts published in DDW,
UEGW and APDW over the past 10 years were also manually
searched. Both randomized controlled trials and case-control
studies were included. The relative risks (RR) of HCC with or
without CHB treatment were studied.
Results: Twelve studies compared IFN (n=1,292) versus control
(n=1,450) and showed that the overall risk of HCC after treat-
ment was reduced by 34% (RR 0.66, 95%CI 0.48-0.89). Beneﬁt is
more signiﬁcant among patients with early cirrhosis than those
without. Four studies compared the risk of HCC development af-
ter using NA (n=1,267) versus control (n=1,022). The overall risk
of HCC after treatment was reduced by 78% (RR 0.22, 95%CI 0.10-
0.50). HBeAg positive patients showed more signiﬁcant reduced
HCC risk with treatment. Patients with cirrhosis beneﬁted more
from the treatment than those without cirrhosis. Resistance to
NA has obviated the beneﬁt of the treatment.
Conclusions: Both IFN and NA showed signiﬁcant reduction in
risk of developing HCC. While IFN treatment beneﬁted patients
with early cirrhosis, NA treatment beneﬁted patients with HBeAg
positive CHB infection, with or without drug resistance or early
cirrhosis.
